Showing results (51-60 of 345) with videos related to
Sort By:
Pageof 35
Clinical Chemistry and Laboratory Medicine|December 4, 2004
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary riskGöran Walldius, Ingmar Jungner, Are H Aastveit, et al.Archives of Internal Medicine|October 13, 2006
The FDA and drug safety: a proposal for sweeping changesCurt D Furberg, Arthur A Levin, Peter A Gross, et al.Journal of the American Heart Association|October 15, 2016
Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein CholesterolAllan D Sniderman, Shofiqul Islam, Matthew McQueen, et al.Journal of the American Geriatrics Society|March 28, 2008
Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health StudyCurt D Furberg, Jeanenne J Nelson, Cam Solomon, et al.Preventive Medicine|October 12, 2010
Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physiciansAnthony J Viera, Stacey L Sheridan, Teresa Edwards, et al.JAMA|January 8, 2004
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002Randall S Stafford, Curt D Furberg, Stan N Finkelstein, et al.Clinical Science (London, England : 1979)|December 23, 2011
The causal exposure model of vascular diseaseAllan D Sniderman, Patrick R Lawler, Ken Williams, et al.British Journal of Hospital Medicine (London, England : 2005)|February 1, 2020
Artificial intelligence and melanoma detection: friend or foe of dermatologists?Maria Charalambides, Sonal SinghCurrent Infectious Disease Reports|March 12, 2011
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: How Significant is the Risk of Pneumonia and Should It Impact Use of Inhaled Corticosteroids?Rodrigo Cavallazzi, Sonal SinghTherapeutic Advances in Drug Safety|August 2, 2014
Varenicline and cardiovascular adverse events: a perspective reviewYohalakshmi Chelladurai, Sonal SinghPageof 35